Aromatherapy in Alzheimer's disease: a randomised controlled trial in comparison with Aricept
Phase 1
- Conditions
- This is a trial of Aricept versus placebo versus aromatherapy in people with Alzheimer's disease.
- Registration Number
- EUCTR2005-003269-17-GB
- Lead Sponsor
- manchester mental health and social care trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Diagnosis of Alzheimer's disease and agitation
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years)
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Sensitivity to cholinesterase inhibitors.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To assess the efficacy of Aricept against aromatherapy in people with agitation in Alzheimer's disease.;Secondary Objective: To assess the impact on quality of life of these treatments in people with Alzheimer's disease.;Primary end point(s): Change in measures of agitation.
- Secondary Outcome Measures
Name Time Method